Cargando…
Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
Chronic lymphocytic leukemia (CLL) is a disease of malignant CD5+ B lymphocytes that are characterized by frequent expression of autoreactive B-cell receptors (BCRs) and marked dependence on microenvironmental signals for proliferation and survival. Among the latter, signals propagated through the B...
Autores principales: | Efremov, Dimitar G., Wiestner, Adrian, Laurenti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499997/ https://www.ncbi.nlm.nih.gov/pubmed/23170196 http://dx.doi.org/10.4084/MJHID.2012.067 |
Ejemplares similares
-
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
por: Efremov, Dimitar G., et al.
Publicado: (2020) -
CLL kinetics in the tumor microenvironment
por: Sun, Clare, et al.
Publicado: (2017) -
Pathogenesis of CLL: the view from the lymph node
por: Wiestner, Adrian
Publicado: (2018) -
Validating genomic tools for precision medicine in CLL: ERIC leads the way
por: Wiestner, Adrian
Publicado: (2021) -
Therapeutic Targets in Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2020)